[HTML][HTML] Psychomotor slowing in schizophrenia: implications for endophenotype and biomarker development
Motor abnormalities (eg, dyskinesia, psychomotor slowing, neurological soft signs) are core
features of schizophrenia that occur independent of drug treatment and are associated with …
features of schizophrenia that occur independent of drug treatment and are associated with …
Psychomotor Slowing in Schizophrenia: Implications for Endophenotype and Biomarker Development.
KJ Osborne, S Walther, SA Shankman… - Biomarkers in …, 2020 - boris.unibe.ch
Motor abnormalities (eg, dyskinesia, psychomotor slowing, neurological soft signs) are core
features of schizophrenia that occur independent of drug treatment and are associated with …
features of schizophrenia that occur independent of drug treatment and are associated with …
Psychomotor Slowing in Schizophrenia: Implications for Endophenotype and Biomarker Development.
KJ Osborne, S Walther, SA Shankman… - Biomarkers in …, 2020 - europepmc.org
Motor abnormalities (eg, dyskinesia, psychomotor slowing, neurological soft signs) are core
features of schizophrenia that occur independent of drug treatment and are associated with …
features of schizophrenia that occur independent of drug treatment and are associated with …
Psychomotor slowing in Schizophrenia: Implications for endophenotype and biomarker development
KJ Osborne, S Walther… - Biomarkers in …, 2020 - scholars.northwestern.edu
Motor abnormalities (eg, dyskinesia, psychomotor slowing, neurological soft signs) are core
features of schizophrenia that occur independent of drug treatment and are associated with …
features of schizophrenia that occur independent of drug treatment and are associated with …
[PDF][PDF] Biomarkers in Neuropsychiatry
KJ Osborne, S Walther, SA Shankman, VA Mittal - scholar.archive.org
Motor abnormalities (eg, dyskinesia, psychomotor slowing, neurological soft signs) are core
features of schizophrenia that occur independent of drug treatment and are associated with …
features of schizophrenia that occur independent of drug treatment and are associated with …
[HTML][HTML] Psychomotor Slowing in Schizophrenia: Implications for Endophenotype and Biomarker Development
KJ Osborne, S Walther, SA Shankman… - Biomarkers in …, 2020 - ncbi.nlm.nih.gov
Motor abnormalities (eg, dyskinesia, psychomotor slowing, neurological soft signs) are core
features of schizophrenia that occur independent of drug treatment and are associated with …
features of schizophrenia that occur independent of drug treatment and are associated with …
Psychomotor Slowing in Schizophrenia: Implications for Endophenotype and Biomarker Development
KJ Osborne, S Walther… - Biomarkers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Motor abnormalities (eg, dyskinesia, psychomotor slowing, neurological soft signs) are core
features of schizophrenia that occur independent of drug treatment and are associated with …
features of schizophrenia that occur independent of drug treatment and are associated with …